LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Positive response of a recurrent clear cell sarcoma to anlotinib combined with chemotherapy: A case report

Photo by nci from unsplash

Rationale: Renal clear cell sarcoma is a rare and highly invasive malignant renal tumor that easily relapses after treatment. Recurrent recurrent clear cell carcinoma (CCSK) responds poorly to chemotherapy and… Click to show full abstract

Rationale: Renal clear cell sarcoma is a rare and highly invasive malignant renal tumor that easily relapses after treatment. Recurrent recurrent clear cell carcinoma (CCSK) responds poorly to chemotherapy and has no established standardized treatment, and need to be explored potentially useful treatments. Patient concerns: A 18-years-old patient with renal clear cell sarcoma recurrence after open radical nephrectomy. Diagnosis: Recurrent clear cell sarcoma. Interventions: After chemotherapy alone failed, the patient received 6 courses of anlotinib combined with chemotherapy. The tumor had significantly reduced in size and the recurrent tumor and part of the liver were resected. Outcomes: No tumor recurrence or metastasis was detected during the follow-up 8 months after the operation. Lessons: This is the first report describing the use of anlotinib in treating CCSK. We believe that anlotinib combined with chemotherapy may be a useful treatment option for patients with recurrent CCSK.

Keywords: cell; anlotinib combined; cell sarcoma; recurrent clear; clear cell

Journal Title: Medicine
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.